• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABT-263诱导的衰老细胞清除与源自非衰老状态的癌细胞固有的凋亡依赖性相关。

Senolysis by ABT-263 is associated with inherent apoptotic dependence of cancer cells derived from the non-senescent state.

作者信息

Jochems Fleur, Baltira Chrysiida, MacDonald Julie A, Daniels Veerle, Mathur Abhijeet, de Gooijer Mark C, van Tellingen Olaf, Letai Anthony, Bernards René

机构信息

Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands.

Division of Pharmacology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands.

出版信息

Cell Death Differ. 2025 May;32(5):855-865. doi: 10.1038/s41418-024-01439-7. Epub 2024 Dec 21.

DOI:10.1038/s41418-024-01439-7
PMID:39706991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12089325/
Abstract

Cellular senescence is a stress response that cells can employ to resist cell death. Senescent cells rely on anti-apoptotic signaling for their survival, which can be targeted by senolytic agents, like the BCL-XL, BCL-2, BCL-W inhibitor ABT-263. However, the response to ABT-263 of senescent cancer cells ranges from highly sensitive to refractory. Using BH3 profiling, we identify here apoptotic blocks in cancer cells that are resistant to this senolytic treatment and discover a correlation between mitochondrial apoptotic priming and cellular sensitivity to ABT-263 in senescence. Intriguingly, ABT-263 sensitivity correlates with overall mitochondrial apoptotic priming, not only in senescence but also in the parental state. Moreover, we confirm that ABT-263 exposure increases dependency on MCL-1, which is most enhanced in ABT-263 sensitive cells. ABT-263 resistant cells however upregulate MCL-1, while sensitive cells exhibit low levels of this anti-apoptotic protein. Overall, our data indicate that the response of senescent cells to ABT-263 is predetermined by the mitochondrial apoptotic priming state of the parental cells, which could serve as a predictive biomarker for response to senolytic therapy.

摘要

细胞衰老 是一种应激反应,细胞可借此来抵抗细胞死亡。衰老细胞依靠抗凋亡信号来存活,而衰老细胞溶解剂(如BCL-XL、BCL-2、BCL-W抑制剂ABT-263)可作用于这些抗凋亡信号。然而,衰老癌细胞对ABT-263的反应程度从高度敏感到难治不等。通过BH3分析,我们在此确定了对这种衰老细胞溶解治疗有抗性的癌细胞中的凋亡阻滞,并发现衰老过程中线粒体凋亡启动与细胞对ABT-263的敏感性之间存在关联。有趣的是,ABT-263敏感性不仅在衰老细胞中,而且在亲代状态下都与整体线粒体凋亡启动相关。此外,我们证实ABT-263处理会增加细胞对MCL-1的依赖性,这在ABT-263敏感细胞中增强最为明显。然而,ABT-263抗性细胞会上调MCL-1,而敏感细胞中这种抗凋亡蛋白的水平较低。总体而言,我们的数据表明,衰老细胞对ABT-263的反应由亲代细胞的线粒体凋亡启动状态预先决定,这可作为衰老细胞溶解疗法反应的预测生物标志物。

相似文献

1
Senolysis by ABT-263 is associated with inherent apoptotic dependence of cancer cells derived from the non-senescent state.ABT-263诱导的衰老细胞清除与源自非衰老状态的癌细胞固有的凋亡依赖性相关。
Cell Death Differ. 2025 May;32(5):855-865. doi: 10.1038/s41418-024-01439-7. Epub 2024 Dec 21.
2
Apoptotic priming in senescence predicts specific senolysis by quantitative analysis of mitochondrial dependencies.通过线粒体依赖性的定量分析,衰老中的凋亡引发可预测特定的衰老细胞溶解。
Cell Death Differ. 2025 May;32(5):802-817. doi: 10.1038/s41418-024-01431-1. Epub 2025 Jan 6.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
7
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
8
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).纳武单抗用于成人霍奇金淋巴瘤(使用RobotReviewer软件进行的快速综述)
Cochrane Database Syst Rev. 2018 Jul 12;7(7):CD012556. doi: 10.1002/14651858.CD012556.pub2.

引用本文的文献

1
The Role of Senescence, its Therapeutic Relevance and Clinical Implications in the Tumor Microenvironment.衰老在肿瘤微环境中的作用、其治疗相关性及临床意义
Theranostics. 2025 Jul 28;15(16):8675-8703. doi: 10.7150/thno.112633. eCollection 2025.
2
Beyond polarization: macrophage senescence in immunoregulation and cancer therapy.超越极化:巨噬细胞衰老在免疫调节和癌症治疗中的作用
Int J Biol Sci. 2025 Jun 23;21(10):4312-4333. doi: 10.7150/ijbs.115921. eCollection 2025.
3
Extracellular vesicles from ovarian cancer cells induce senescent lipid-laden macrophages to facilitate omental metastasis.卵巢癌细胞释放的细胞外囊泡可诱导衰老的脂质负载巨噬细胞,促进大网膜转移。
J Nanobiotechnology. 2025 Jul 26;23(1):540. doi: 10.1186/s12951-025-03612-7.

本文引用的文献

1
BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models.BRD-810 是一种高选择性的 MCL1 抑制剂,具有优化的体内清除率和在实体瘤和血液瘤模型中的强大疗效。
Nat Cancer. 2024 Oct;5(10):1479-1493. doi: 10.1038/s43018-024-00814-0. Epub 2024 Aug 23.
2
Anti-apoptotic MCL-1 promotes long-chain fatty acid oxidation through interaction with ACSL1.抗凋亡蛋白 MCL-1 通过与 ACSL1 相互作用促进长链脂肪酸氧化。
Mol Cell. 2024 Apr 4;84(7):1338-1353.e8. doi: 10.1016/j.molcel.2024.02.035. Epub 2024 Mar 18.
3
Dormant cancer cells: programmed quiescence, senescence, or both?休眠癌细胞:程序性静止、衰老还是两者兼有?
Cancer Metastasis Rev. 2023 Mar;42(1):37-47. doi: 10.1007/s10555-022-10073-z. Epub 2023 Jan 4.
4
Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression.靶向抗凋亡途径可消除衰老的黑素细胞并导致痣消退。
Nat Commun. 2022 Dec 23;13(1):7923. doi: 10.1038/s41467-022-35657-9.
5
Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis.通过靶向线粒体凋亡增强基于自然杀伤细胞的免疫疗法。
Cell. 2022 Apr 28;185(9):1521-1538.e18. doi: 10.1016/j.cell.2022.03.030. Epub 2022 Apr 20.
6
Apoptosis: Directly Targeted at Last.细胞凋亡:最终直接成为靶点。
J Clin Oncol. 2022 May 20;40(15):1693-1695. doi: 10.1200/JCO.22.00304. Epub 2022 Mar 23.
7
Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development.衰老细胞为何对凋亡具有抗性:衰老细胞裂解剂开发的见解
Front Cell Dev Biol. 2022 Feb 16;10:822816. doi: 10.3389/fcell.2022.822816. eCollection 2022.
8
Exploiting senescence for the treatment of cancer.利用衰老治疗癌症。
Nat Rev Cancer. 2022 Jun;22(6):340-355. doi: 10.1038/s41568-022-00450-9. Epub 2022 Mar 3.
9
Cellular senescence: all roads lead to mitochondria.细胞衰老:条条大路通线粒体。
FEBS J. 2023 Mar;290(5):1186-1202. doi: 10.1111/febs.16361. Epub 2022 Jan 30.
10
The Cancer SENESCopedia: A delineation of cancer cell senescence.《癌症衰老词典》:癌症细胞衰老描绘。
Cell Rep. 2021 Jul 27;36(4):109441. doi: 10.1016/j.celrep.2021.109441.